Taxation - Reconciliations of income tax expense/(benefit) (Details) ¥ in Thousands, $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
|
Dec. 31, 2024
CNY (¥)
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
CNY (¥)
|
Dec. 31, 2022
CNY (¥)
|
|
| Reconciliations of the income tax expenses | ||||
| (Loss)/Income before income tax | ¥ 9,315,624 | $ 1,276,236 | ¥ 10,451,763 | ¥ (2,159,355) |
| Income tax (benefit)/expense computed at PRC statutory income tax rate of 25% | 2,328,906 | 2,612,941 | (539,839) | |
| Tax effect of taxexempt entity and preferential tax rate | (797,326) | (1,613,371) | (321,507) | |
| Tax effect of Super R&D Deduction and others | (954,781) | (1,055,404) | (648,317) | |
| Non-deductible expenses | 611,424 | 512,572 | 566,597 | |
| Change in valuation allowance | 82,151 | (1,814,100) | 816,059 | |
| Income tax (benefit)/expense | ¥ 1,270,374 | $ 174,041 | ¥ (1,357,362) | ¥ (127,007) |
| PRC statutory tax rate (in percent) | 25.00% | 25.00% | ||
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income exempt from income tax because of a tax holiday. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|